Alexander Dömling, PhD, Chief Scientific Officer and Co-Founder of Carmolex, is Chair of Drug Design, University of Groningen, and is a world authority in multi-component reaction chemistry with valuable industry and academic experience in the field of drug discovery/development and medicinal chemistry and more than 100 peer reviewed papers.. He leads the chemistry development and quality control for customers.